April 12 (Reuters) - MITHRA PHARMACEUTICALS SA MITRA.BR :
* SIGNS PRINCIPLE AGREEMENT FOR ESTELLE COMMERCIALIZATION IN CANADA WITH SEARCHLIGHT PHARMA
* TOP LINE RESULTS FOR ESTELLE PHASE 3 TRIALS EXPECTED IN Q3 2018 AND Q1 2019
* ELIGIBLE TO RECEIVE UP TO EUR 15 MILLION IN UPFRONT PAYMENTS AND SALES-RELATED REVENUES
* TO MANUFACTURE ESTELLE FOR SEARCHLIGHT AND RECEIVE GUARANTEED ANNUAL RECURRING REVENUES
* THE ANNUAL RECURRING REVENUES TO BE BASED ON MINIMUM ANNUAL QUANTITIES
* AGREEMENT COULD ACHIEVE REVENUES OF AT LEAST EUR 50 MILLION FOR MITHRA